Benitec Limited (ASX:BLT) (PINK:BNIKF) are pleased to announce the publication of a paper in the prestigious scientific journal Cancer Research by Associate Professor Maria Kavallaris from Children's Cancer Institute Australia for Medical Research (CCIA) and the University of New South Wales (UNSW), relating to the association between beta tubulin and chemotherapy resistance in cancers.
Benitec Limited (ASX:BLT) PINK:BNIKF) are pleased to announce that Dr Peter French has been appointed CEO of Benitec, effective immediately. Dr French has been Benitec's Chief Scientific Officer since August 2009.
Benitec Limited (ASX:BLT) (PINK:BNIKF) provides the following update on the USA Patent Re-examination of the "Graham" patent 6,573,099. In response to the formal Request for Oral Hearing filed in March 2010 and as announced in our market update on 9 March 2010, the Company has been notified that the Board of Patent Appeals and Interferences of the United States Patent and Trademark Office will hold an oral hearing re this matter on Wednesday 4 August 2010.
Benitec Limited (ASX:BLT) (PINK:BNIKF) are delighted to announce the appointment of Mr Iain Ross to the Board.
The Australian shares opened slightly lower this morning with weak overseas lead. Fitch Ratings has downgraded Spain's credit rating from AAA to AA-plus, saying the country's economic recovery will be more muted than the government forecast. The local market is under pressure after the downgrade fuelled concerns over the Eurozone crisis.
iSOFT Group Limited (ASX:ISF), Australia's largest listed health information technology company today announced the appointment of Dr. James (Jim) Fox as Deputy Chairman. This decision affirms the Board's commitment to the continual process of review and development of the Company's overall corporate governance position and the composition of the Board.
Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB) (ADR:MBLTY), was featured yesterday by the ASX at its inaugural Small to Mid Caps Conference in Singapore.
